Fosfomic en es it fr

Fosfomic Brand names, Fosfomic Analogs

Fosfomic Brand Names Mixture

  • No information avaliable

Fosfomic Chemical_Formula


Fosfomic RX_link

Fosfomic fda sheet

Fosfomic FDA

Fosfomic msds (material safety sheet)

Fosfomic Synthesis Reference

M. Winn et al., U.S. Pat. 4,026,894 (1977)

Fosfomic Molecular Weight

387.433 g/mol

Fosfomic Melting Point

273 oC

Fosfomic H2O Solubility


Fosfomic State


Fosfomic LogP


Fosfomic Dosage Forms


Fosfomic Indication

For the treatment of symptomatic benign prostatic hyperplasia (BPH) and also for hypertension.

Fosfomic Pharmacology

Terazosin, classified as a quinazoline, is similar to doxazosin and prazosin. As an alpha-adrenergic blocking agent, terazosin is used to treat hypertension and benign prostatic hypertrophy (BPH). Terazosin produces vasodilation and reduces peripheral resistance but in general has slight effect on cardiac output. Antihypertensive effect with chronic dosing is usually not accompanied by reflex tachycardia.

Fosfomic Absorption

Essentially completely absorbed in man (90% bioavailability).

Fosfomic side effects and Toxicity

LD50=259.3mg/kg (i.v. in mice)

Fosfomic Patient Information

Fosfomic Organisms Affected

Humans and other mammals